TECH
BIO-TECHNE Corp
NASDAQ · Healthcare · Biotechnology · US
$72.37
−0.06%Margins
Gross margin
65.8%
EBITDA margin
28.3%
EBIT margin
20.7%
Net margin
15.0%
FCF margin
21.7%
8.6%
Return on equity
7.0%
Return on assets
10.5%
Return on invested capital
0.47x
Asset turnover
$292.1M
Cash from operations
$1.69
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026